These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11040272)

  • 1. The status of high-dose chemotherapy in breast cancer.
    Rodenhuis S
    Oncologist; 2000; 5(5):369-75. PubMed ID: 11040272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
    JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?
    Crown J
    Lancet; 2003 Aug; 362(9385):677-8. PubMed ID: 12957087
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose chemotherapy in high-risk breast cancer.
    Price LA
    Lancet; 1998 Nov; 352(9139):1551-2. PubMed ID: 9820326
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose chemotherapy in breast cancer--interpretation of the randomized trials.
    Rodenhuis S
    Anticancer Drugs; 2001 Feb; 12(2):85-8. PubMed ID: 11261891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy for breast cancer: is another look warranted?
    Nieto Y; Jones RB; Shpall EJ
    Curr Opin Oncol; 2004 Mar; 16(2):114-9. PubMed ID: 15075901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dose density and dose intensity in the treatment of breast cancer].
    Saintigny P; Assouad S; Gligorov J; Selle F; Roché H; Breau JL; Morère JF; Lotz JP
    Bull Cancer; 2004 Dec; 91 Suppl 4():S244-53. PubMed ID: 15899616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer.
    Baselga J; Perez EA; Pienkowski T; Bell R
    Oncologist; 2006; 11 Suppl 1():4-12. PubMed ID: 16971734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy in breast cancer.
    Lake DE; Hudis CA
    Drugs; 2004; 64(17):1851-60. PubMed ID: 15329034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy of breast cancer: update.
    Cufer T
    Ann Oncol; 1999; 10 Suppl 6():129-37. PubMed ID: 10676564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discouraging news for high-dose chemotherapy in high-risk breast cancer.
    Pusztai L; Hortobagyi GN
    Lancet; 1998 Aug; 352(9127):501-2. PubMed ID: 9716049
    [No Abstract]   [Full Text] [Related]  

  • 12. [New data concerning breast carcinoma. A report on the 34th Meeting of the American Society of Clinical Oncology, Los Angeles, Calif., USA, May 16-19, 1998].
    Gerber B; Krause A
    Gynakol Geburtshilfliche Rundsch; 1999; 39(3):136-9. PubMed ID: 10420058
    [No Abstract]   [Full Text] [Related]  

  • 13. [San Antonio Breast Cancer Symposium 2003. New therapeutic prospects in the treatment of early-stage breast cancer].
    Montemurro F
    Tumori; 2004; 90(1):suppl 1-16. PubMed ID: 15143995
    [No Abstract]   [Full Text] [Related]  

  • 14. [High-dose chemotherapy in breast cancer].
    Schmid P; Possinger K
    Med Klin (Munich); 2002 Nov; 97(11):677-86. PubMed ID: 12434276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study].
    Mallmann P
    Internist (Berl); 2006 Nov; 47(11):1183-5. PubMed ID: 17048017
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy in high-risk primary breast cancer.
    Schmid P; Possinger K
    Onkologie; 2002 Apr; 25(2):112-20. PubMed ID: 12006761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of adjuvant chemotherapy of breast cancer from Bonadonna to the taxanes].
    Nagykálnai T
    Magy Onkol; 2002; 46(4):307-13. PubMed ID: 12563352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanes.
    Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Hayes S; Howell A
    Eur J Cancer; 1997 Nov; 33(13):2171-82. PubMed ID: 9470803
    [No Abstract]   [Full Text] [Related]  

  • 20. When an interim analysis of randomized trial changes the practice in oncology: the lesson of adjuvant Trastuzumab and the HERA trial.
    De Rossi C; Brunello A; Jirillo G; Jirillo A
    Immunopharmacol Immunotoxicol; 2009 Mar; 31(1):30-1. PubMed ID: 21054206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.